Results 21 to 30 of about 165,122 (254)

Lactic Acid Bacteria Isolated from Fresh Vegetable Products: Potential Probiotic and Postbiotic Characteristics Including Immunomodulatory Effects

Microorganisms, 2022
The ability to perform effectively in the gastrointestinal tract (GIT) is one of the most significant criteria in the selection of potential probiotic bacteria.
Fatima Alameri, Mohammad Tarique, Tareq Osaili, Riyad Obaid, Abdelmoneim Abdalla, Razan Masad, Ashraf Al-Sbiei, Maria Fernandez-Cabezudo, Shao-Quan Liu, Basel Al-Ramadi, Mutamed Ayyash   +10 more
doaj   +1 more source

Low-density lipoprotein cholesterol lowering treatment: the current approach

Lipids in Health and Disease, 2020
In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions.
Irina Crismaru, Anca Pantea Stoian, Ovidiu Gabriel Bratu, Mihnea-Alexandru Gaman, Ana Maria Alexandra Stanescu, Nicolae Bacalbasa, Camelia Cristina Diaconu   +6 more
doaj   +1 more source

Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol.

Journal of Lipid Research, 1994
The National Cholesterol Education Program (NCEP) has recommended that dietary total fat, saturated fat, and cholesterol intake be reduced to < or = 30% of calories, < 10% of calories, and < 300 mg/day, respectively (Step 1 diet) in the general ...
J Lopez-Miranda, J.M. Ordovas, P Mata, A.H Lichtenstein, B Clevidence, J.T Judd, E.J Schaefer   +6 more
doaj   +1 more source

Association between sociodemographic factors and cholesterol-lowering medication use in U.S. adults post-myocardial infarction

PLoS ONE, 2023
Introduction Cholesterol-lowering medications offer effective secondary prevention after myocardial infarction (MI). Our objective was to evaluate the association between sociodemographic factors and cholesterol-lowering medication use in high-risk ...
Elizabeth T. Mansi, Samantha Banks, Alyson J. Littman, Noel S. Weiss   +3 more
doaj   +2 more sources

Targeted Strategy in Lipid-Lowering Therapy

Biomedicines, 2022
Dyslipidemia is characterized by a diminished lipid profile, including increased level of total cholesterol and low-density lipoprotein cholesterol (LDL-c) and reduced level of high-density lipoprotein cholesterol (HDL-c). Lipid-lowering agents represent
Ezgi Dayar, Olga Pechanova
doaj   +1 more source

Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics

Signal Transduction and Targeted Therapy, 2022
Disturbed cholesterol homeostasis plays critical roles in the development of multiple diseases, such as cardiovascular diseases (CVD), neurodegenerative diseases and cancers, particularly the CVD in which the accumulation of lipids (mainly the ...
Yajun Duan, Ke Gong, Suowen Xu, Feng Zhang, Xianshe Meng, Jihong Han   +5 more
doaj   +1 more source

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis

Frontiers in Psychiatry, 2021
Introduction: Antipsychotic-induced dyslipidemia represents a common adverse effect faced by patients with schizophrenia that increases risk for developing further metabolic complications and cardiovascular disease.
Pruntha Kanagasundaram, Pruntha Kanagasundaram, Jiwon Lee, Jiwon Lee, Femin Prasad, Femin Prasad, Kenya A. Costa-Dookhan, Kenya A. Costa-Dookhan, Laurie Hamel, Madeleine Gordon, Madeleine Gordon, Gary Remington, Gary Remington, Gary Remington, Margaret K. Hahn, Margaret K. Hahn, Margaret K. Hahn, Margaret K. Hahn, Sri Mahavir Agarwal, Sri Mahavir Agarwal, Sri Mahavir Agarwal, Sri Mahavir Agarwal   +21 more
doaj   +1 more source

LDL-Cholesterol-Lowering Therapy [PDF]

, 2020
AbstractThe causal relation between elevated levels of LDL-C and cardiovascular disease has been largely established by experimental and clinical studies. Thus, the reduction of LDL-C levels is a major target for the prevention of cardiovascular disease.
Giuseppe Danilo Norata, Angela Pirillo, Alberico L. Catapano   +2 more
openaire   +3 more sources

45. Ezetimibe and statins yields on silent holter ambulatory myocardial ischemia

Journal of the Saudi Heart Association, 2016
Further cholestrol lowering may affect silent ischemia detected on holter monitoring. Cholesterol lowering is associated with a reduction in cardiovascular morbidity and mortality. Statins are the main drugs for cholesterol lowering. Ezetimibe when added
W. Kadro
doaj   +1 more source

Trends in lipid profiles and descriptive characteristics of U.S. adults with and without diabetes and cholesterol-lowering medication use-National Health and Nutrition Examination Survey, 2003-2012, United States.

PLoS ONE, 2018
BackgroundWith a cholesterol-lowering focus for diabetic adults and in the age of polypharmacy, it is important to understand how lipid profile levels differ among those with and without diabetes.ObjectiveInvestigate the means, differences, and trends in
Carla I Mercado, Edward Gregg, Cathleen Gillespie, Fleetwood Loustalot   +3 more
doaj   +1 more source